Guy Handley @handleyg.bsky.social · 24/06/2025Great board review resource getting so much information into one book! 120
Reposted by Guy HandleyScience Friday @scifri.bsky.social · 21/02/2025In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine had no signs of relapse after three years. Dr. Vinod Balachandran from @mskcancercenter.bsky.social joins us to discuss the results and what they could mean for cancer treatment.buff.lyA Vaccine For Pancreatic Cancer Continues To Show PromiseIn a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later. 686240265576
Reposted by Guy HandleyWilliam F Wright @wwrighid.bsky.social · 14/12/2024#IDSky #AMR #PharmSky @idsainfo.bsky.social 🚨 On December 13, 2024, ASM and IDSA announced partnership to an annual conference on antimicrobial resistance starting in 2026! Cesar Arias, M.D., Ph.D., M.S., and Greg Moeck, Ph.D., are Co-Chairs of the Program Committee. asm.org/Press-Releas...asm.orgASM and IDSA to Launch New Conference on AMRASM and IDSA partner to create an annual AMR conference to explore the latest advances in antimicrobial drug discovery and development, mechanisms of resistance, pharmacological aspects and more. 1208
Reposted by Guy HandleyUSF Infectious Disease Fellowship @usfidfellowship.bsky.social · 12/12/2024We are thrilled to announce our 2025 USF ID Fellows! Welcome to USF ID family! #UStayForever #USF #GoBulls #IDSky #FellowshipMatch #Match #usfid 091
Reposted by Guy HandleyPancreatic Cancer Action Network @pancan.bsky.social · 11/12/2024Voting for the official 2025 #PanCANPurpleStride T-Shirt design has begun! 💜 To cast your vote, register for your local event at purplestride.org! Then, you'll receive an email to submit your pick. 📧 Voting ends on Wednesday, 12/18! 📅 Once you vote, make sure to raise $50+ to secure your shirt! ✅ 031
Reposted by Guy HandleyPancreatic Cancer Action Network @pancan.bsky.social · 10/12/2024The annual #PanCANPurpleStride T-shirt is a BIG deal! 💜 Our Founder, Pam Acosta Marquardt, even had this special blanket created from all her past T-shirts! 😍 Starting TOMORROW, all registered Striders can cast their vote for their favorite 2025 T-shirt design 🗳 Register now at purplestride.org! 051
Reposted by Guy HandleyLuis Ostrosky, MD, FIDSA @drluiso.bsky.social · 07/12/2024Beyond happy with our match and our new class of fellows at UTHealth Houston 091
Reposted by Guy HandleyAlex Sundermann, DrPH @sundermannaj.bsky.social · 30/11/2024Had a great chat with Tori Whitacre Martonicz from Infection Control Today on some of our recent research with genomic surveillance for healthcare outbreaks ⤵️ “Genomic Surveillance A New Frontier in Health Care Outbreak Detection” #IDSky #MedSky www.infectioncontroltoday.com/view/genomic...infectioncontroltoday.comGenomic Surveillance A New Frontier in Health Care Outbreak DetectionAccording to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, ... 1194
Reposted by Guy HandleySteven Pergam, MD, MPH @pergamic.bsky.social · 26/11/2024📢 Brand new ID faculty position just posted @fredhutch.bsky.social in Seattle. Join our ID group that studies infections in immunocompromised hosts. The Emerald city has great academics, phenomenal facilities, outstanding collaborators - all in amazing surroundings. apply.interfolio.com/159913 57833
Guy Handley @handleyg.bsky.social · 23/11/2024Critical point for Infection Control. Also the difference between HZ and DZ can be very subtle and changes over time 031
Guy Handley @handleyg.bsky.social · 21/11/2024New practice guideline from NCCN this month including prophylaxis and CAR T-cell therapy updates. Very handy for clinicians and researchers! pubmed.ncbi.nlm.nih.gov/39536464/pubmed.ncbi.nlm.nih.govPrevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology - PubMedThere is an increased risk of infection in patients with cancer that results in higher morbidity and mortality. Several risk factors can predispose these patients to infectious complications. Some suc... 2226
Reposted by Guy HandleySteven Pergam, MD, MPH @pergamic.bsky.social · 18/11/2024New virtual meeting for Immunocompromised Host Society: Addressing the Landscape of CMV Management in Transplant Recipients. Free to members or $25 plus a free membership for those not already members! Forward on to your residents, fellows, grad students, and international colleagues #TxID #CMV 21410
Reposted by Guy HandleyAnthony Cannella, MD, MSc, FACP, FIDSA @apcmd.bsky.social · 18/11/2024Good morning! It’s #AntibioticStewardshipWeek! Prompting awareness for the sensible use of antibiotics and using PO ABx when you can. 😊💊👨🏻⚕️ #IDSky #AMR 1275
Reposted by Guy HandleyIlan Schwartz @germhuntermd.bsky.social · 16/11/2024Cementing the professional legitimacy of 🦋 We now have the journals on #MedSky & #IDSky @jamacurrent.bsky.social @bmj.com @cmicomms.bsky.social (first one?) @eurosurveillance.bsky.social @cidjournal.bsky.social @ofidjournal.bsky.social @thejhi.bsky.social @jclinical-invest.bsky.social 24279104
Guy Handley @handleyg.bsky.social · 16/11/2024Fantastic discussion yesterday with leaders in the field about NIH funding, clinical trials, national society/guidelines. Great for early career physicians and looking forward to the next meeting 020
Reposted by Guy HandleySETID @se-tid.bsky.social · 16/11/2024We want to thank our expert panel for leading our first seminar this year "Building a Research Portfolio in Transplant ID!" Look out for our upcoming series in the new year and message us if interested!! 1) Hepatitis B in SOT 2) Challenging Cases in TxID 3) CMV and SCT 032
Reposted by Guy HandleyAntibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 15/11/2024Both letermovir & maribavir can be perpetrator or victim of a drug–drug interaction 🆕️🔥 #CPK Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir & Maribavir: Guidance for Clinicians #idsky ✨️tables✨️ #bookmark link.springer.com/article/10.1...link.springer.comDrug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians - Clinical PharmacokineticsLetermovir and maribavir have demonstrated efficacy in the prevention and treatment, respectively, of immunosuppressed patients with cytomegalovirus (CMV) infection and disease. These patients often h... 1266
Reposted by Guy HandleyRemington Winter Course in Infectious Diseases @wintercourseid.bsky.social · 14/11/2024ID is a crucial specialty in medicine, yet applications for fellowship have declined. In CIDJournal, Collin Telchik, MD, MPH, & colleagues evaluate interest in ID among med students & identify factors associated with interest/disinterest in ID @idsainfo.bsky.social academic.oup.com/cid/advance-...academic.oup.comGauging Medical Students’ Interests in Infectious DiseasesSummary: This study investigates medical students’ interest in infectious diseases, identifying critical factors shaping their career choices. The findings 001
Reposted by Guy HandleyIlan Schwartz @germhuntermd.bsky.social · 11/11/2024#IDSky Starter Packs (Updated 11/11/24) IDSky 1 go.bsky.app/LnAQjdq IDSky 2 go.bsky.app/JNfSvQT IDSky 3 go.bsky.app/FeogT7o IDSky 4 go.bsky.app/D1zxj4E TxID go.bsky.app/95rzmLi MedMycology go.bsky.app/8XGywEx Let me know if I missed you! cc #MedSkymedia.tenor.coma man in a suit and tie stands in front of a group of people and says there are dozens of usAlt: Tobias Fünke standing if front of a crowd in a brown suit, yelling "There are dozens of us. DOZENS!" while pointing to the sky 3210851